Liver cancer remains an evolving indication for liver transplantation in the year 2012 as advances are made in patient selection, neoadjuvant treatment and living-donor liver transplantation. Patient survival is improving and, as patient selection and treatment advances, more transplantations can be conducted on patients with liver cancer.